Jane Street
LGND icon

Jane Street’s Ligand Pharmaceuticals LGND Stock Holding History

Jane Street’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Buy
+2,100
New +$415K ﹤0.01% 8461
2025
Q4 		– Sell
-9,600
Closed -$1.7M – 11838
2025
Q3 		$1.7M Buy
+9,600
New +$1.43M ﹤0.01% 5241
2022
Q1 		– Sell
-3,527
Closed -$340K – 10708
2021
Q4 		$340K Sell
3,527
-3,847
-52% -$355K ﹤0.01% 7941
2021
Q3 		$641K Buy
7,374
+962
+15% +$74.4K ﹤0.01% 6807
2021
Q2 		$525K Sell
6,412
-467,275
-99% -$38.9M ﹤0.01% 7142
2021
Q1 		$45M Buy
473,687
+436,978
+1,190% +$41.3M 0.02% 530
2020
Q4 		$2.28M Sell
36,709
-40,235
-52% -$2.29M ﹤0.01% 3264
2020
Q3 		$4.58M Sell
76,944
-98,424
-56% -$6.72M ﹤0.01% 1946
2020
Q2 		$12.2M Buy
175,368
+157,575
+886% +$9.99M 0.01% 1048
2020
Q1 		$807K Buy
+17,793
New +$1.01M ﹤0.01% 3046
2019
Q1 		– Sell
-10,900
Closed -$923K – 5365
2018
Q4 		$923K Buy
+10,900
New +$1.16M ﹤0.01% 2683
2017
Q2 		– Sell
-100,188
Closed -$6.62M – 4652
2017
Q1 		$6.62M Buy
+100,188
New +$6.59M 0.03% 550
2016
Q2 		– Sell
-6,412
Closed -$428K – 4350
2016
Q1 		$428K Buy
+6,412
New +$390K ﹤0.01% 2772

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Jane Street's LGND Position: Q1 2026 in Review

Jane Street reduced its Ligand Pharmaceuticals (LGND) stake by 19% in Q1 2026, selling an estimated $605K and leaving 12,906 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4623.

Jane Street first reported a position in LGND in Q2 2013 and has held it in 35 quarters since. The position peaked at $9.19M in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Jane Street held 12,906 shares of Ligand Pharmaceuticals worth $2.58M as of Q1 2026.
  • Jane Street sold 3,056 Ligand Pharmaceuticals shares in Q1 2026, an estimated $605K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4623 holding.
  • Jane Street first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 35 quarters since.
  • Jane Street's Ligand Pharmaceuticals position peaked at $9.19M in Q3 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.